Healthcare provider profile · identity verified

Rhodora A Sy, MD

Family Practice · MANTENO, IL · NPI 1710085535

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	900	265
Levothyroxine Sodium	Levothyroxine Sodium	610	130
Amlodipine Besylate	Amlodipine Besylate	583	181
Lisinopril	Lisinopril	343	100
Losartan Potassium	Losartan Potassium	324	97
Alendronate Sodium	Alendronate Sodium	256	71
Metoprolol Succinate	Metoprolol Succinate	243	79
Pantoprazole Sodium	Pantoprazole Sodium	227	74
Hydrochlorothiazide	Hydrochlorothiazide	226	69
Metformin Hcl	Metformin Hcl	195	61
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	182	54
Omeprazole	Omeprazole	172	50
Metoprolol Tartrate	Metoprolol Tartrate	167	47
Simvastatin	Simvastatin	167	46
Carvedilol	Carvedilol	159	49
Potassium Chloride	Potassium Chloride	156	46
Escitalopram Oxalate	Escitalopram Oxalate	146	45
Furosemide	Furosemide	143	42
Gabapentin	Gabapentin	135	35
Alprazolam	Alprazolam	131	25
Metformin Hcl Er	Metformin Hcl	119	43
Ozempic	Semaglutide	119	20
Ezetimibe	Ezetimibe	117	30
Albuterol Sulfate Hfa	Albuterol Sulfate	107	38
Rosuvastatin Calcium	Rosuvastatin Calcium	103	36
Allopurinol	Allopurinol	100	28
Clopidogrel	Clopidogrel Bisulfate	99	24
Citalopram Hbr	Citalopram Hydrobromide	86	19
Eliquis	Apixaban	84	21
Sertraline Hcl	Sertraline Hcl	81	21
Januvia	Sitagliptin Phosphate	79	14
Tizanidine Hcl	Tizanidine Hcl	75	30
Glipizide	Glipizide	72	19
Glimepiride	Glimepiride	67	21
Fluticasone Propionate	Fluticasone Propionate	64	27
Trazodone Hcl	Trazodone Hcl	64	17
Montelukast Sodium	Montelukast Sodium	60	17
Tramadol Hcl	Tramadol Hcl	59	18
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	52	15
Lorazepam	Lorazepam	52	14
Tamsulosin Hcl	Tamsulosin Hcl	51	14
Paroxetine Hcl	Paroxetine Hcl	50	13
Jardiance	Empagliflozin	47	11
Mirtazapine	Mirtazapine	45	12
Warfarin Sodium	Warfarin Sodium	44	12
Spironolactone	Spironolactone	43	17
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	suppressed
Hydralazine Hcl	Hydralazine Hcl	41	14
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	11
Famotidine	Famotidine	39	suppressed
Xarelto	Rivaroxaban	38	11
Atenolol	Atenolol	37	suppressed
Azithromycin	Azithromycin	36	36
Lovastatin	Lovastatin	36	11
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	36	31
Methylprednisolone	Methylprednisolone	35	31
Glipizide Er	Glipizide	34	13
Venlafaxine Hcl Er	Venlafaxine Hcl	34	suppressed
Cephalexin	Cephalexin	33	30
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	32	11
Amoxicillin	Amoxicillin	30	26
Benazepril Hcl	Benazepril Hcl	30	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Memantine Hcl	Memantine Hcl	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Clonidine Hcl	Clonidine Hcl	29	suppressed
Enalapril Maleate	Enalapril Maleate	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	28	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	28	13
Klor-Con M20	Potassium Chloride	28	suppressed
Synthroid	Levothyroxine Sodium	28	suppressed
Celecoxib	Celecoxib	26	suppressed
Meclizine Hcl	Meclizine Hcl	26	suppressed
Duloxetine Hcl	Duloxetine Hcl	25	12
Temazepam	Temazepam	23	suppressed
Entresto	Sacubitril/Valsartan	22	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	22	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Bupropion Hcl Sr	Bupropion Hcl	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Spiriva Respimat	Tiotropium Bromide	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Tresiba Flextouch U-100	Insulin Degludec	19	suppressed
Acyclovir	Acyclovir	17	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	15
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Glyburide	Glyburide	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	15	suppressed
Calcitriol	Calcitriol	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	14	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	14	suppressed
Donepezil Hcl	Donepezil Hcl	14	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	14	suppressed
Sotalol	Sotalol Hcl	14	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	14	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Bumetanide	Bumetanide	13	suppressed
Buspirone Hcl	Buspirone Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Lidocaine	Lidocaine	13	suppressed
Linzess	Linaclotide	13	suppressed
Nystatin	Nystatin	13	suppressed
Tresiba Flextouch U-200	Insulin Degludec	13	suppressed
Ventolin Hfa	Albuterol Sulfate	13	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Finasteride	Finasteride	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Topiramate	Topiramate	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Carbamazepine Er	Carbamazepine	11	suppressed
Cefdinir	Cefdinir	11	11
Fentanyl	Fentanyl	11	suppressed
Methocarbamol	Methocarbamol	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error